| Year |
Title |
Altmetric |
| 2022
|
The neural substrates of neurological soft signs in schizophrenia: a systematic review.
npj Schizophrenia.
8.
2022
|
|
| 2022
|
Contrasting Frontoparietal Network Connectivity in Antipsychotic Medication-Naive First-Episode Psychosis Patients Who Do and Do Not Display Features of the Deficit Syndrome.
Schizophrenia Bulletin.
48:1344-1353.
2022
|
|
| 2022
|
Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients with First-Episode Psychosis Who Are Antipsychotic Naive.
JAMA Psychiatry.
79:1133-1138.
2022
|
|
| 2022
|
Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia.
Brain and Behavior.
12.
2022
|
|
| 2022
|
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies.
Schizophrenia Research.
249:74-84.
2022
|
|
| 2022
|
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.
Schizophrenia Research.
249:4-15.
2022
|
|
| 2022
|
In vivo Experience With NRT to Increase Adherence and Smoking Abstinence Among Individuals in the Criminal Legal System: Study Protocol for a Randomized Clinical Trial.
Frontiers in Psychiatry.
13.
2022
|
|
| 2022
|
Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol.
Frontiers in Psychiatry.
13.
2022
|
|
| 2022
|
Hippocampal Dysconnectivity and Altered Glutamatergic Modulation of the Default Mode Network: A Combined Resting-State Connectivity and Magnetic Resonance Spectroscopy Study in Schizophrenia.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
7:108-118.
2022
|
|
| 2021
|
Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
6:1185-1192.
2021
|
|
| 2021
|
White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients.
Molecular Psychiatry.
26:5347-5356.
2021
|
|
| 2021
|
Clinical utility of wearable sensors and patient-reported surveys in patients with schizophrenia: Noninterventional, observational study.
JMIR Mental Health.
8.
2021
|
|
| 2021
|
White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Naïve First-Episode Psychosis Patients.
Schizophrenia Bulletin.
47:1068-1076.
2021
|
|
| 2021
|
Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis.
European Neuropsychopharmacology.
47:11-19.
2021
|
|
| 2021
|
Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia.
Frontiers in Psychiatry.
12.
2021
|
|
| 2021
|
A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis.
Journal of Psychiatry and Neuroscience.
46:E702-E710.
2021
|
|
| 2021
|
Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment
2021
|
|
| 2021
|
Salience network glutamate and brain connectivity in medication-naïve first episode patients – A multimodal magnetic resonance spectroscopy and resting state functional connectivity MRI study.
NeuroImage: Clinical.
32.
2021
|
|
| 2021
|
Structural and Functional Default Mode Network Connectivity and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
2021
|
|
| 2020
|
A multimodal magnetoencephalography 7 T fMRI and 7 T proton MR spectroscopy study in first episode psychosis.
npj Schizophrenia.
6.
2020
|
|
| 2020
|
Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis.
Translational Psychiatry.
10.
2020
|
|
| 2020
|
Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.
Translational Psychiatry.
10.
2020
|
|
| 2020
|
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.
Neuropsychopharmacology.
45:1842-1850.
2020
|
|
| 2020
|
White matter and neurite morphology differ in psychogenic nonepileptic seizures.
Annals of Clinical and Translational Neurology.
7:1973-1984.
2020
|
|
| 2020
|
Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic-naïve first-episode psychosis subjects.
Human Brain Mapping.
41:2999-3008.
2020
|
|
| 2020
|
A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia
2020
|
|
| 2020
|
Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
5:231-238.
2020
|
|
| 2020
|
Baseline Functional Connectivity Predicts Connectivity Changes Due to a Small Dose of Midazolam in Older Adults.
Anesthesia and Analgesia.
130:224-232.
2020
|
|
| 2019
|
A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder.
Neuropsychopharmacology.
44:1932-1939.
2019
|
|
| 2019
|
Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.
Journal of Psychiatric Research.
117:108-115.
2019
|
|
| 2019
|
A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
Schizophrenia Research.
210:239-244.
2019
|
|
| 2019
|
A pilot study of combined endurance and resistance exercise rehabilitation for verbal memory and functional connectivity improvement in epilepsy.
Epilepsy and Behavior.
96:44-56.
2019
|
|
| 2019
|
Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
4:462-471.
2019
|
|
| 2019
|
Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.
Schizophrenia Research.
204:262-270.
2019
|
|
| 2019
|
Relationship Between Cortical Excitation and Inhibition and Task-Induced Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
4:121-130.
2019
|
|
| 2019
|
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Schizophrenia Bulletin.
45:180-189.
2019
|
|
| 2019
|
Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG.
NeuroImage: Clinical.
24.
2019
|
|
| 2018
|
Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment.
Frontiers in Psychiatry.
9.
2018
|
|
| 2018
|
Digital trajectories to care in first-episode psychosis.
Psychiatric Services.
69:1259-1263.
2018
|
|
| 2018
|
Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication.
npj Schizophrenia.
4.
2018
|
|
| 2018
|
Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients.
Psychiatry Research: Neuroimaging.
281:101-106.
2018
|
|
| 2018
|
A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia.
Frontiers in Psychiatry.
9.
2018
|
|
| 2018
|
Four-way multimodal fusion of 7 T imaging data using an mCCA+jICA model in first-episode schizophrenia.
Human Brain Mapping.
39:1475-1488.
2018
|
|
| 2018
|
Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
3:231-238.
2018
|
|
| 2018
|
Paving the way for targeted drug development in schizophrenia.
JAMA Psychiatry.
75:19-20.
2018
|
|
| 2017
|
Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder- A systematic review of the magnetic resonance neuroimaging literature.
npj Schizophrenia.
3.
2017
|
|
| 2017
|
Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms.
Journal of Psychiatric Research.
91:169-176.
2017
|
|
| 2017
|
Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
Molecular Psychiatry.
22:562-569.
2017
|
|
| 2017
|
The effect of saccadic eye movements on the sensor-level magnetoencephalogram.
Clinical Neurophysiology.
128:397-407.
2017
|
|
| 2017
|
Risperidone effects on brain dynamic connectivity-A prospective resting-state fMRI study in Schizophrenia.
Frontiers in Psychiatry.
8.
2017
|
|
| 2017
|
Predictors of medication adherence and smoking cessation among smokers under community corrections supervision.
Addictive Behaviors.
65:111-117.
2017
|
|
| 2016
|
Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional mri study.
Schizophrenia Bulletin.
42:1046-1055.
2016
|
|
| 2016
|
Biochemistry of the cingulate cortex in autism: An MR spectroscopy study
2016
|
|
| 2016
|
Change in brain network topology as a function of treatment response in schizophrenia: A longitudinal resting-state fMRI study using graph theory.
npj Schizophrenia.
2.
2016
|
|
| 2016
|
A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
Schizophrenia Research.
170:341-350.
2016
|
|
| 2016
|
Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone.
NeuroImage: Clinical.
10:146-158.
2016
|
|
| 2016
|
Making progress toward individualized medicine in the treatment of psychosis.
American Journal of Psychiatry.
173:5-7.
2016
|
|
| 2016
|
Rapid clozapine titration in an acutely agitated patient with schizoaffective disorder a case report.
Journal of Clinical Psychopharmacology.
36:276-277.
2016
|
|
| 2015
|
Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.
Schizophrenia Research.
168:543-553.
2015
|
|
| 2015
|
Cognitive risk profiles for anxiety disorders in a high-risk population.
Psychiatry Research.
229:572-576.
2015
|
|
| 2015
|
Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers.
American Journal of Preventive Medicine.
49:335-344.
2015
|
|
| 2015
|
SLC7A1 expression is associated with seizures, predicts poor survival in patients with malignant glioma.
Science Translational Medicine.
7.
2015
|
|
| 2015
|
Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates.
Cortex.
66:46-59.
2015
|
|
| 2015
|
Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication.
Human Brain Mapping.
36:1442-1457.
2015
|
|
| 2015
|
A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls.
NeuroInformatics.
13:7-18.
2015
|
|
| 2015
|
Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: A combined magnetic resonance spectroscopy/functional imaging study.
npj Schizophrenia.
1.
2015
|
|
| 2014
|
Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia
2014
|
|
| 2014
|
How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference.
Nicotine and Tobacco Research.
16:1348-1355.
2014
|
|
| 2014
|
Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.
Neuropsychopharmacology.
39:1020-1030.
2014
|
|
| 2014
|
Delay discounting and task performance consistency in patients with schizophrenia.
Psychiatry Research.
215:286-293.
2014
|
|
| 2014
|
Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.
Psychiatry Research.
221:6-12.
2014
|
|
| 2014
|
Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy.
Nicotine and Tobacco Research.
16.
2014
|
|
| 2014
|
In reply.
JAMA Psychiatry.
71:339-340.
2014
|
|
| 2014
|
Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: Preliminary findings.
Frontiers in Pharmacology.
5 JUL.
2014
|
|
| 2014
|
Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: Relationship to treatment and treatment response.
Neuropsychopharmacology.
39:2095-2103.
2014
|
|
| 2014
|
Vergence eye movements in patients with schizophrenia.
Vision Research.
102:64-70.
2014
|
|
| 2013
|
Memory deficits in Schizophrenia: A selective review of functional magnetic resonance imaging (fMRI) studies.
Behavioral Sciences.
3:330-347.
2013
|
|
| 2013
|
XSpatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.
Cell.
154.
2013
|
|
| 2013
|
An fMRI investigation of delay discounting in patients with schizophrenia.
Brain and Behavior.
3:384-401.
2013
|
|
| 2013
|
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
Schizophrenia Research.
147:348-354.
2013
|
|
| 2013
|
Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology.
Biological Psychiatry.
73:289-294.
2013
|
|
| 2013
|
Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
JAMA Psychiatry.
70:1294-1302.
2013
|
|
| 2012
|
Ocular convergence deficits in schizophrenia.
Frontiers in Psychiatry.
3.
2012
|
|
| 2012
|
Antipsychotic drugs alter functional connectivity between the medial frontal cortex, hippocampus, and nucleus accumbens as measured by H215O PET.
Frontiers in Psychiatry.
3.
2012
|
|
| 2012
|
Regional decoupling of n-acetyl-aspartate and glutamate in schizophrenia.
Neuropsychopharmacology.
37:2635-2642.
2012
|
|
| 2012
|
Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
Schizophrenia Research.
140:136-142.
2012
|
|
| 2012
|
Heritability of functioning in families with schizophrenia in relation to neurocognition.
Schizophrenia Research.
139:105-109.
2012
|
|
| 2012
|
Neurometabolites in schizophrenia and bipolar disorder - A systematic review and meta-analysis.
Psychiatry Research.
203:111-125.
2012
|
|
| 2011
|
Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia.
Psychiatry Research.
193:138-143.
2011
|
|
| 2011
|
Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia.
Neuropsychopharmacology.
36:1779-1780.
2011
|
|
| 2011
|
Mitochondria in the striatum of subjects with schizophrenia: Relationship to treatment response
2011
|
|
| 2010
|
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.
Biological Psychiatry.
68:625-633.
2010
|
|
| 2010
|
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.
Neuropsychopharmacology.
35:632-640.
2010
|
|
| 2009
|
Modulation of limbic circuitry predicts treatment response to antipsychotic medication: A functional imaging study in schizophrenia.
Neuropsychopharmacology.
34:2675-2690.
2009
|
|
| 2009
|
Dopaminergic synapses in the caudate of subjects with schizophrenia: Relationship to treatment response
2009
|
|
| 2006
|
Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
American Journal of Psychiatry.
163:488-493.
2006
|
|
| 2006
|
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia.
Neuropsychopharmacology.
31:221-230.
2006
|
|
| 2005
|
Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.
Neuropsychopharmacology.
30:2275-2282.
2005
|
|
| 2005
|
The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Psychopharmacology.
183:265-274.
2005
|
|
| 2005
|
Subtle effects of ketamine on memory when administered following stimulus presentation.
Psychopharmacology.
180:385-390.
2005
|
|
| 2005
|
Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.
Psychiatry Research.
139:19-30.
2005
|
|
| 2004
|
Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations.
Psychiatry Research.
127:207-216.
2004
|
|
| 2004
|
Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex.
Neuropsychopharmacology.
29:171-178.
2004
|
|
| 2003
|
Schizophrenia, VIII.
American Journal of Psychiatry.
160:2091.
2003
|
|
| 2003
|
Functional effects of antipsychotic drugs: Comparing clozapine with haloperidol.
Biological Psychiatry.
53:601-608.
2003
|
|
| 2002
|
Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.
American Journal of Psychiatry.
159:1490-1496.
2002
|
|
| 2001
|
Probing the human hippocampus using rCBF: Contrasts in schizophrenia
2001
|
|
| 2001
|
Perceptual skill and brain physiology in subgroups of persons with schizophrenia..
Dialogues in Clinical Neuroscience.
3:294-295.
2001
|
|
| 2001
|
Treatments for chronic psychosis..
Dialogues in Clinical Neuroscience.
3:281-292.
2001
|
|
| 2001
|
Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.
American Journal of Psychiatry.
158:1797-1808.
2001
|
|
| 2001
|
Effects of ketamine in normal and schizophrenic volunteers.
Neuropsychopharmacology.
25:455-467.
2001
|
|
| 2001
|
Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically.
Neuropsychopharmacology.
25:165-172.
2001
|
|
| 2001
|
Long-term outcome of patients who receive ketamine during research.
Biological Psychiatry.
49:869-875.
2001
|
|
| 2000
|
Ketamine effects on eye movements.
Neuropsychopharmacology.
23:645-653.
2000
|
|
| 2000
|
The limbic cortex in schizophrenia: Focus on the anterior cingulate.
Brain Research Reviews.
31:364-370.
2000
|
|
| 2000
|
Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task.
American Journal of Psychiatry.
157:1634-1645.
2000
|
|
| 2000
|
Decisional capacity for informed consent in schizophrenia research.
JAMA Psychiatry.
57:533-538.
2000
|
|
| 1999
|
Nmda-sensitive glutamate antagonism: A human model for psychosis.
Neuropsychopharmacology.
21:S158-S169.
1999
|
|
| 1999
|
Treatment of schizophrenia 1999.
Journal of Clinical Psychiatry.
60:3-80.
1999
|
|
| 1998
|
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia.
Journal of Neural Transmission.
105:719-734.
1998
|
|
| 1998
|
Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers.
Cerebral Cortex.
8:534-542.
1998
|
|
| 1998
|
Smooth pursuit eye movements to extraretinal motion signals: Deficits in relatives of patients with schizophrenia.
JAMA Psychiatry.
55:830-836.
1998
|
|
| 1998
|
The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.
Schizophrenia Research.
31:141-150.
1998
|
|
| 1998
|
Antipsychotic properties of the partial dopamine agonist (-)-3-(3- hydroxyphenyl)-N-n-propylpiperidine (preclamol) in schizophrenia.
Biological Psychiatry.
43:2-11.
1998
|
|
| 1998
|
Association between eye tracking disorder in schizophrenia and poor sensory integration.
American Journal of Psychiatry.
155:1352-1357.
1998
|
|
| 1998
|
Specific measures account for most of the variance in qualitative ratings of smooth pursuit eye movements in schizophrenia..
JAMA Psychiatry.
55:184-186.
1998
|
|
| 1998
|
Time course of rCBF changes after acute haloperidol in patients with schizophrenia.
NeuroImage.
7.
1998
|
|
| 1997
|
Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome.
Biological Psychiatry.
42:781-796.
1997
|
|
| 1997
|
Clinical genetics, V: Association of genetic and personality characteristics.
American Journal of Psychiatry.
154:1496.
1997
|
|
| 1996
|
Does pursuit abnormality in schizophrenia represent a deficit in the predictive mechanism?.
Psychiatry Research.
59:221-237.
1996
|
|
| 1996
|
Absence of ketamine effects on memory and other cognitive functions in schizophrenic patients.
Journal of Psychiatric Research.
30:321-330.
1996
|
|
| 1996
|
Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients.
American Journal of Psychiatry.
153:1158-1165.
1996
|
|
| 1995
|
Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions.
International Clinical Psychopharmacology.
10:29-37.
1995
|
|
| 1995
|
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
NeuroReport.
6:869-872.
1995
|
|
| 1995
|
Recent developments in the neuropharmacology of schizophrenia.
American Journal of Health-System Pharmacy.
52.
1995
|
|
| 1995
|
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
Neuropsychopharmacology.
13:9-19.
1995
|
|
| 1993
|
Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia.
American Journal of Psychiatry.
150:66-71.
1993
|
|
| 1991
|
Tobacco smoking increases square-wave jerks during pursuit eye movements.
Biological Psychiatry.
29:82-88.
1991
|
|
| 1990
|
Psychiatric Morbidity in Research Volunteers.
JAMA Psychiatry.
47:980.
1990
|
|
